CIPO Patents = 11 (Patent Applications = 1)

EPO Patents = 8 (Patent Applications = 3)

Average Co-Inventor Count = 2.5

ph-index = 8

Forward Citations = 326(Granted Patents)

Location History:

Mission Viejo, CA (US) (2006)
Edwardsburg, MI (US) (1992 - 2020)

Company Filing History:

Ascensia Diabetes Care Holdings Ag

5. 1 out of 832,680

Other

patents

Years Active: 1992-2020

Loading Chart...

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10724985 - Biosensor for determining a concentration of a biosensor using an underfill procedure (2020-07-28),

2. 10261044 - Electrochemical test sensor (2019-04-16),

3. 9939406 - Underfill detection system for a biosensor (2018-04-10),

4. 9459229 - Electrochemical test sensor (2016-10-04),

5. 9301717 - Determining analyte concentrations in biological fluids with abnormal output detection (2016-04-05),

6. 9239312 - Methods of determining analyte concentration having enhanced stability and hematocrit performance (2016-01-19),

7. 8973422 - Underfill detection system for a biosensor (2015-03-10),

8. 8877035 - Gated amperometry methods (2014-11-04),

9. 8841133 - Temperature-adjusted analyte determination for biosensor systems (2014-09-23),

10. 8728299 - Biosensor performance increasing methods having enhanced stability and hematocrit performance (2014-05-20),

11. 8702965 - Biosensor methods having enhanced stability and hematocrit performance (2014-04-22),

12. 8445290 - Temperature-adjusted analyte determination for biosensor systems (2013-05-21),

13. 8425757 - Gated amperometry (2013-04-23),

14. 8234076 - Abnormal output detection system for a biosensor (2012-07-31),

15. 8184273 - Method of determining glucose concentration of a whole blood sample (2012-05-22),

Title: Innovations and Contributions of Christine D Nelson

Introduction

Christine D Nelson is an accomplished inventor located in Edwardsburg, MI, known for her significant contributions to the field of biosensing and electrochemical analysis. With a remarkable portfolio of 23 patents, she has established herself as a leader in developing innovative technologies that enhance the accuracy and reliability of biological fluid analyses.

Latest Patents

Some of Christine's latest patents include groundbreaking technologies such as a biosensor designed for determining the concentration of analytes through an underfill detection system. This biosensor utilizes an excitation signal to analyze biological fluid samples, ensuring that the sample size is adequate for accurate testing. Additionally, she holds a patent for electrochemical sensor strips that enhance the methods of determining analyte concentrations, focusing on improving performance and stability under various conditions.

Career Highlights

Christine has worked with prominent companies in the healthcare industry, including Bayer Healthcare LLC and Ascensia Diabetes Care Holdings AG. Her work in these organizations has contributed immensely to developing devices that assist in monitoring and managing health conditions, particularly in diabetes care.

Collaborations

Throughout her career, Christine has collaborated with notable colleagues, including Huan-Ping Wu and Hope Spradlin. These collaborations have fostered an innovative environment that emphasizes teamwork and shared goals, driving forward the development of cutting-edge technologies in the biomedical field.

Conclusion

Christine D Nelson continues to make vital strides in innovation and technology through her patents and professional collaborations. Her commitment to improving biosensing and electrochemical analysis exemplifies her role as a pioneering inventor in her field, contributing to advancements that positively impact healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.